Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Rett syndrome (RTT) and Fragile X syndrome (FXS) are monogenetic neurodevelopmental disorders with complex clinical presentations.
• RTT arises from mutations in the Methyl-CpG binding protein 2 gene (MECP2), affecting MeCP2 protein function.
• FXS results from FMR1 gene silencing, impacting Fragile X Mental Retardation Protein (FMRP) and RNA metabolism.

Purpose of the Study:

• To investigate overlapping features and differences in RTT and FXS.
• To discuss altered synaptic function and plasticity in these disorders.
• To explore potential interactions between MeCP2 and FMRP in neurodevelopmental pathophysiology.

Main Methods:

• Comparative analysis of molecular mechanisms in RTT and FXS.
• Review of literature on MeCP2 and FMRP functions.
• Examination of synaptic function and plasticity alterations.

Main Results:

• Overlapping clinical features suggest shared molecular signaling dysregulation.
• MeCP2 and FMRP regulate common targets involved in brain activity.
• Both disorders exhibit altered synaptic function and plasticity.

Conclusions:

• Despite distinct genetic origins, RTT and FXS share pathophysiological pathways.
• Interactions between MeCP2 and FMRP may contribute to overlapping symptoms.
• Understanding these shared mechanisms is crucial for therapeutic strategies.